I-Cholesterol ephezulu kanye nesifo sikashukela kuyi-Recipe yenhliziyo embi
Ososayensi bathola ubufakazi bokuthi isifo sikashukela ngokwayo sibheka ubuhlungu nge- cholesterol , okwandisa kakhulu amathuba okuhlaselwa yinhliziyo noma isifo sohlangothi ngisho nangaphezulu. Izibopho eziseduze phakathi kwalezi zici ezimbili zengozi zisho ukuthi uma unesifo sikashukela, kufanele uqaphe kakhulu ngokulawula i-cholesterol yakho.
Xhumanisa Phakathi kwe-Insulin ne-Cholesterol
Abacwaningi basacacisa kahle ukuthi isifo sikashukela sishintsha kanjani amazinga e-cholesterol ezingeni lamangqamuzana amancane.
Bayazi ukuthi amazinga aphakeme e-insulini egazini athambekele ekuthinteni inani lezinhlayiya ze-cholesterol egazini.
Amazinga aphezulu e-insulin enza ukuphakamisa inani le-LDL-cholesterol ("i-cholesterol embi") ejwayele ukwenza ama- plaques emitheni ye-arteries bese yehlisa inani lezinhlayiya ze-cholesterol ze- HDL ("i-cholesterol enhle") esisiza ukukhipha amapuletiki ayingozi ngaphambi kokuba aphule ngaphandle kokubangela isifo senhliziyo noma isifo sohlangothi. Isifo sikashukela sivame ukudala amazinga aphezulu e- triglycerides , olunye uhlobo lwamafutha ajikeleza egazini.
Ngokufanayo, i-cholesterol ephezulu ingaba isifo sikashukela; Amazinga e-cholesterol ephakeme ngokuvamile abonakala kubantu abane-insulin ukumelana, ngisho nangaphambi kokuba bahlakulele isifo sikashukela esigcwele. Lapho amazinga e-LDL eqala ukukhuphuka, ochwepheshe batusa ukunakekelwa okusheshayo ekulawuleni ushukela wegazi nokuqala ukudla nokuzivocavoca ukusiza ukuvimbela isifo sikashukela nesifo senhliziyo.
Lokhu kubaluleke kakhulu uma unomlando womndeni wesifo senhliziyo.
Kubantu abanesifo sikashukela sohlobo 1 , ukulawula ushukela wegazi kungenza umehluko omkhulu. Ukulawulwa kokushukela okuhle kwegazi kuhlotshaniswa namazinga e-cholesterol aseduze-evamile, afana nalawo abonakala kubantu abangenayo isifo sikashukela. Kodwa abantu abanesifo sikashukela sohlobo lwe-Type 1 bakwazi ukukhulisa amazinga e-triglyceride namazinga aphansi e-HDL, okufaka isandla ekwakhiweni kwemithambo yegazi.
Thayipha isifo sikashukela sesi-2: Ingozi enkulu kakhulu ephuma ku-High Cholesterol
Abantu abanesifo sikashukela sohlobo lwe-2 , kungakhathaliseki ukulawulwa ushukela egazini, bavame ukukhuphula i-triglycerides , behla i-HDL, futhi ngezinye izikhathi banda i-LDL. Le phrofayli ye-cholesterol ingaphikelela ngisho noma amazinga kashukela egazi alawulwa - okukhomba ukuthi kunamathuba angcono kakhulu okuthuthukisa amapulethi. Eqinisweni, ama-plaque akhiwe emithanjeni yabantu abane-Type 2 yesifo sikashukela ngokuvamile ayamafutha futhi angaphansi kwe-fibrous kunabantu abanesifo sikashukela soHlobo 1, okuholela engozini enkulu nakakhulu yokukhipha i-plaque ukudala ukuhlasela kwenhliziyo noma ukushaya isisu.
I-American Diabetes Association ikhuthaza ukuncoma amazinga e-cholesterol okungenani kanye ngonyaka, noma kaningi uma iphakeme futhi ingalawulwa yimithi. Kubantu abanesifo sikashukela kanye nesifo senhliziyo esaziwayo, kunconywa ukuthi amazinga e-LDL egazini abe ngaphansi kwezigidi eziyi-100 nge-deciliter (mg / dL), ukuthi amazinga e-HDL abe ngaphezu kuka-50 mg / dL, futhi i-triglycerides engaphansi kuka-150 mg / dL. I-sugar recommended ye-blood, noma i-glucose, izinga lingaphansi kuka-7% (<7%) kuhlolo lwe-HA1C.
Kubantu abanesifo sikashukela kanye nesifo senhliziyo esaziwayo, kuhlanganise nemithanguzo evinjiwe noma ukuhlaselwa kwenhliziyo, i-ADA ikhuthaza i-LDL ngezansi kwe 70 mg / dL.
Ukufinyelela kulo mgomo ophansi kakhulu we-LDL kungadinga ukulingana okuphezulu kwemithi ye-statin, kodwa kuboniswa ukunciphisa kakhulu ingozi yokuhlaselwa yinhliziyo. Amazinga we-Triglyceride kufanele abe ngaphansi kuka-150 mg / dL ne-HDL ngaphezulu kuka-40 mg / dL. Abesifazane abanesifo sikashukela kanye nesifo se-coronary heart ekhona banconywa ukuba babe namazinga e-HDL ngaphezulu kuka-50 mg / dL.
Imithi eyodwa, i- WelChol (colesevelam), iboniswe ukunciphisa kokubili i-glucose namazinga e-cholesterol kubantu abaneSifo 2 sikashukela. I-Welchol yenza ngokuvimbela amathumbu ukuba athole ama-molecule amaningi ekudleni. Nakuba i-Welchol inamazinga aphansi e- LDL , ingakhulisa amazinga e-triglyceride egazini, futhi akufanele isetshenziswe ngabantu abane-triglycerides ephezulu.
I-Metabolic Syndrome ne-Cholesterol
Abantu abanenkinga yezifo ezinjenge-insulin ukumelana, amazinga we-cholesterol ampofu, ukucindezeleka kwegazi nokukhuluphala kuthiwa unesifo se-metabolic syndrome (esaziwa nangokuthi i-syndrome X). Ucwaningo luye lwathola ukuthi iziguli ezine-HDL ephansi kanye ne-triglyceride ephezulu-izimpawu zesifo se-metabolic syndrome - zinengozi enkulu yokuhlupheka kwesifo senhliziyo noma isifo sohlangothi. Abantu abanephrofayli ye-cholesterol nabo bayazuza kakhulu emithonjeni ye-statin.
Izingozi ezihlukahlukene zesifo senhliziyo zivela esandleni futhi kufanele ziphathwe ndawonye. Abantu abanesifo sikashukela - abanengozi enkulu yosuku olulodwa abahlukunyezwa inhliziyo - kufanele baqaphele ikakhulukazi ngokugcina ushukela wegazi kanye ne-cholesterol emazingeni aphansi. Kubalulekile nokugcina isisindo esinempilo nokucindezeleka kwegazi okuphansi nokugwema ukubhema.
Imithombo:
Association of American Diabetes Association. "I-ADA Isikhundla Isitatimende: Amazinga Okunakekelwa Kwezokwelapha Esifo Sikashukela." Ukunakekelwa kwesifo sikashukela 30 (2007): Ukusekela 1.
UMcCulloch, uDavid K. "Uhlolojikelele Lwezokunakekelwa Kwezokwelapha Kwabantu Abadala abanesifo Sikashukela Mellitus." UpToDate.com. 2008. UpToDate. 6 Apreli 2008. (ukubhalisa)
Meigs, James B. "I-Metabolic Syndrome (Insulin Resistance Syndrome noma i-Syndrome X)." UpToDate.com. 2008. UpToDate. 7 Mashi 2008. (ukubhalisa)
U-Nesto, uRichard W. "Izingozi Zezifo NeziNhlekelele Ze-Coronary Heart Diabetes Mellitus." UpToDate.com. 2008. UpToDate. 6 Apreli 2008. (ukubhalisa)
I-Pyorala, K., et al. "Ukunciphisa Izenzakalo Zezinhliziyo Ze-Simvastatin E-Nondiabetic Coronary Heart Disease Iziguli Ezingazange Zingaphinde Zisebenzise I-Metabolic Syndrome: Ukuhlaziywa Kwezingxenye zeSmandinavian Simvastatin Survival Study (4S)." Ukunakekelwa yisifo sikashukela 27 (2004): 1735-40.
U-Rosenson, uRobert S. "Uhlolojikelele Lokwelashwa Kwe-Hypercholesterolemia." UpToDate.com. 2008. UpToDate. 30 Mar2008 (ukubhalisa)
U-Rosenson, uRobert S. "Izimbangela Zesibili Ze-Dyslipidemia." UpToDate.com. 2008. UpToDate. 26 Apreli 2008. (ukubhalisa)
I-Umbiko Wesibili We-National Cholesterol Education Program (NCEP) Iphaneli Yomhloli Ekutholeni, Ukuhlola Nokuphathwa Kwegazi Eliphezulu le-Cholesterol kubantu abadala (i-Adult Treatment Panel III) Umbiko Wokugcina. " Ukujikeleza 106 (2002): 3143.
Zieve, FJ, MF Kalin, SL Schewartz, MR Jones, noWL Bailey. "Imiphumela ye-Glucose-Umphumela Wokunciphisa WelChol Study (GLOWS): Isifundo Sezindiza Esilawulwa Ngama-Double, Blind, EsiPhezulu, Esihlola Ukuthathwa Kwe-Colesevelam Hydrochloride ekulawuleni i-Glycemic in Subjects nge Type 2 Diabetes." I-Clinical Therapeutics 29 (2007): 74-83.